Helicobacter pylori Infections in Children

被引:9
作者
Nguyen, Julie [1 ]
Kotilea, Kallirroi [1 ,2 ]
Bontems, Patrick [1 ,2 ]
Deyi, Veronique Yvette Miendje [2 ,3 ]
机构
[1] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Pediat Gastroenterol, B-1000 Brussels, Belgium
[2] Belgian Helicobacter & Microbiota Study Grp BHMSG, B-1000 Brussels, Belgium
[3] Univ Libre Bruxelles, Dept Microbiol, Lab Hosp Univ Bruxelles Brussel Universitair Lab L, B-1000 Brussels, Belgium
来源
ANTIBIOTICS-BASEL | 2023年 / 12卷 / 09期
关键词
Helicobacter pylori; children; epidemiology; pathogenesis; clinical manifestations; diagnosis; antibiotic resistance and treatment; IRON-DEFICIENCY ANEMIA; RECURRENT ABDOMINAL-PAIN; TRIPLE THERAPY; PEPTIC-ULCER; SEQUENTIAL THERAPY; ERADICATION; GASTRITIS; SUPERIOR; METAANALYSIS; ASSOCIATION;
D O I
10.3390/antibiotics12091440
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In the context of epidemiology, host response, disease presentation, diagnosis, and treatment management, the manifestation of Helicobacter pylori (H. pylori) infection diverges between children and adults. H. pylori infection stands out as one of the most prevalent bacterial infections globally, and its prevalence in both children and adults is decreasing in many developing countries but some still struggle with a high prevalence of pediatric H. pylori infection and its consequences. The majority of infected children are asymptomatic and pediatric studies do not support the involvement of H. pylori in functional disorders such as recurrent abdominal pain. The pathophysiology of H. pylori infection relies on complex bacterial virulence mechanisms and their interaction with the host immune system and environmental factors. This interaction gives rise to diverse gastritis phenotypes, which subsequently influence the potential development of various gastroduodenal pathologies. In clinical settings, the diagnosis of this infection in childhood requires an upper gastrointestinal endoscopic exam with mucosal biopsy samples for histology and culture, or Polymerase Chain Reaction (PCR) at the very least. When warranted, eradication treatment should be given when good compliance is expected, and there should be systematic use of a treatment adapted to the antimicrobial susceptibility profile. To combat the burgeoning threat of multidrug resistance, vigilant surveillance of resistance patterns and strategic antibiotic management are paramount.
引用
收藏
页数:16
相关论文
共 114 条
  • [1] Helicobacter pylori infection in children
    Aguilera Matos, Idalmis
    Diaz Oliva, Sarah Esther
    Escobedo, Angel A.
    Villa Jimenez, Oscar Manuel
    Velazco Villaurrutia, Yamila del Carmen
    [J]. BMJ PAEDIATRICS OPEN, 2020, 4 (01)
  • [2] Helicobacter pylori in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes
    Alexander, Sneha Mary
    Retnakumar, Radhakrishnan Jayalakshmi
    Chouhan, Deepak
    Devi, Thillai Natarajan Barani
    Dharmaseelan, Sanjai
    Devadas, Krishnadas
    Thapa, Namrata
    Tamang, Jyoti Prakash
    Lamtha, Sangey Chhophel
    Chattopadhyay, Santanu
    [J]. FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [3] Alfaray R.I., 2022, Microb. Health Dis, V4, pe543
  • [4] Alimohammadi H., 2016, Eastern Mediterranean Health Journal, V22, P860
  • [5] Time trend prevalence of helicobacter pylori infection and endoscopic findings in symptomatic children in Portugal: A retrospective study based on three time points in 2009, 2014, and 2019
    Antunes, Raquel
    Oleastro, Monica
    Nogueira, Joao Paulo
    Lopes, Ana Isabel
    [J]. HELICOBACTER, 2023, 28 (04)
  • [6] Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population
    Argueta, Erick A.
    Alsamman, Mohd Amer
    Moss, Steven F.
    D'Agata, Erika M. C.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : 2181 - +
  • [7] Tolerance Rather Than Immunity Protects From Helicobacter pylori-Induced Gastric Preneoplasia
    Arnold, Isabelle C.
    Lee, Josephine Y.
    Amieva, Manuel R.
    Roers, Axel
    Flavell, Richard A.
    Sparwasser, Tim
    Mueller, Anne
    [J]. GASTROENTEROLOGY, 2011, 140 (01) : 199 - +
  • [8] Efficacy of a novel sequential treatment regimen containing bismuth forHelicobacter pylorieradication in Turkish children
    Arslan, Melike
    Balamtekin, Necati
    Gunal, Armagan
    [J]. HELICOBACTER, 2020, 25 (06)
  • [9] Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain:: Double blind randomized placebo-controlled trial
    Ashorn, M
    Rägö, T
    Kokkonen, J
    Ruuska, T
    Rautelin, H
    Karikoski, R
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (08) : 646 - 650
  • [10] The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases
    Atherton, John C.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2006, 1 (01) : 63 - 96